Alector (ALEC) Cash & Current Investments (2018 - 2026)

Alector's (ALEC) quarterly Cash & Current Investments came in at $206.5 million in Q1 2026, down 41.75% year-on-year from $354.6 million in Q1 2025, and down 19.34% on a QoQ basis from $256.0 million in Q4 2025.

Alector (ALEC) Cash & Current Investments (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Cash & Current Investments data on file, last reported at $206.5 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 41.75% year-over-year to $206.5 million in Q1 2026; TTM through Mar 2026 was $206.5 million, a 41.75% decrease from a year earlier, with the FY2025 full-year figure at $256.0 million, down 38.07% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $206.5 million, down from $256.0 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for ALEC reached as high as $868.6 million in Q1 2022 and fell as low as $206.5 million in Q1 2026.
  • Historically, Cash & Current Investments has averaged $525.7 million across 5 years, with a median of $548.9 million in 2023.
  • Across the five-year window, Cash & Current Investments soared 153.11% in 2022 and sank 41.75% in 2026, its largest moves.
  • Year by year, Cash & Current Investments stood at $712.9 million in 2022, then fell by 23.0% to $548.9 million in 2023, then slipped by 24.68% to $413.4 million in 2024, then slumped by 38.07% to $256.0 million in 2025, then declined by 19.34% to $206.5 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $206.5 million in Q1 2026, $256.0 million in Q4 2025, and $291.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 65,719.23 Bn 65,718.94 Bn - 283.54 Mn
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - 61.40 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.85 Bn 467.06 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.29 Bn 115.04 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.28 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.47 Bn 959.66 Mn 3.01 Bn
10 Alector 167.54 Mn -38.97 Mn - 206.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 206.52 Mn
Dec 31, 2025 256.02 Mn
Sep 30, 2025 291.11 Mn
Jun 30, 2025 307.28 Mn
Mar 31, 2025 354.55 Mn
Dec 31, 2024 413.40 Mn
Sep 30, 2024 457.20 Mn
Jun 30, 2024 503.33 Mn
Mar 31, 2024 562.08 Mn
Dec 31, 2023 548.86 Mn
Sep 30, 2023 588.86 Mn
Jun 30, 2023 630.05 Mn
Mar 31, 2023 669.33 Mn
Dec 31, 2022 712.85 Mn
Sep 30, 2022 758.31 Mn
Jun 30, 2022 808.86 Mn
Mar 31, 2022 868.57 Mn
Dec 31, 2021 735.25 Mn
Sep 30, 2021 777.85 Mn
Jun 30, 2021 319.57 Mn